Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2006 2
2007 1
2008 2
2009 5
2010 7
2011 7
2012 3
2013 8
2014 5
2015 5
2016 3
2017 3
2018 3
2019 3
2020 9
2021 10
2022 4
2023 1
2024 4
2025 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Female urethral hemangioma.
Uchida K, Fukuta F, Ando M, Miyake M. Uchida K, et al. Among authors: fukuta f. J Urol. 2001 Sep;166(3):1008. J Urol. 2001. PMID: 11490280 Review. No abstract available.
Intrinsic and extrinsic factors causing hyperplasia of the prostate.
Kyoda Y, Shibamori K, Shindo T, Maehana T, Hashimoto K, Kobayashi K, Tanaka T, Fukuta F, Masumori N. Kyoda Y, et al. Among authors: fukuta f. Int J Urol. 2024 Jul;31(7):705-717. doi: 10.1111/iju.15446. Epub 2024 Mar 10. Int J Urol. 2024. PMID: 38462732 Free PMC article. Review.
Traditional Japanese diet and prostate cancer.
Mori M, Masumori N, Fukuta F, Nagata Y, Sonoda T, Sakauchi F, Ohnishi H, Nojima M, Tsukamoto T. Mori M, et al. Among authors: fukuta f. Mol Nutr Food Res. 2009 Feb;53(2):191-200. doi: 10.1002/mnfr.200800285. Mol Nutr Food Res. 2009. PMID: 19101948 Review.
Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era.
Shindo T, Hashimoto K, Fujino K, Takahashi A, Hotta H, Maeda T, Kunishima Y, Fukuta F, Ito N, Wanifuchi A, Kato R, Okada M, Matsukawa M, Horita H, Takayanagi A, Kobayashi K, Tanaka T, Masumori N. Shindo T, et al. Among authors: fukuta f. World J Urol. 2024 May 9;42(1):307. doi: 10.1007/s00345-024-04952-z. World J Urol. 2024. PMID: 38722418
Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching.
Nishiyama N, Kobayashi T, Narita S, Hidaka Y, Ito K, Maruyama S, Mukai S, Tsutsumi M, Miki J, Okuno T, Yoshio Y, Matsumoto H, Shimazui T, Segawa T, Karashima T, Masui K, Fukuta F, Tashiro K, Imai K, Suekane S, Nagasawa S, Higashi S, Fukui T, Kojima T, Morita S, Ogawa O, Nishiyama H, Kitamura H; Japan Urological Oncology Group. Nishiyama N, et al. Among authors: fukuta f. J Geriatr Oncol. 2022 Jan;13(1):88-93. doi: 10.1016/j.jgo.2021.07.002. Epub 2021 Jul 6. J Geriatr Oncol. 2022. PMID: 34238726
73 results